FDA issues regulations on accelerated drug-approval process
Clinical Pharmacy 12(4): 253-254
1993
ISSN/ISBN: 0278-2677 PMID: 8458175 Document Number: 408425
Document emailed within 1 workday
Related Documents
Cohen, M.H.; Johnson, J.R.; Pazdur, R. 2005: U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 11(1): 12-19Gifford, R.W. 1980: The FDA new drug approval process Connecticut Medicine 44(5): 309-311
Anderson, L.F. 1989: Cancer and AIDS groups push for changes in drug approval process Journal of the National Cancer Institute 81(11): 829-831
Wolfe, S.M. 2014: Does $760 m a year of industry funding affect the FDA's drug approval process? Bmj 349: G5012
Fredd, S.B. 1990: The OTC drug approval process. The ACG Committee on FDA-Related Matters. American College of Gastroenterology American Journal of Gastroenterology 85(1): 12-14
Thomas, J.W. 1995: AHi perspectives: flexible drug labeling and its impact on the drug development process. Liability issues Journal of the American Veterinary Medical Association 207(7): 899-900; Discussion: 902-904
Browne, T.R. 1993: Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods Epilepsy Research. Suppl 10: 31-44
Nicholson, C. 2015: Ethical approval in studies raising consent issues Nursing Times 111(3): 18-20
Astrup, K.G.; Riis, P. 1995: Drug approval. Orientation from the drug department of the National Board of Health and Welfare and the scientific-ethical committee system Ugeskrift for Laeger 157(46): 6442-6443
Baumgarten, H.J. 1977: Food regulations as regulations to which penalties are attached before and after their transfer to the sphere of regulations governing illegal actions Fleischwirtschaft 57(11): 1984-1988
Miller, H.I. 2019: FDA's 'Accelerated Approvals' Are Critical But Raise Thorny Issues Missouri Medicine 116(3): 168-169
Stribling, J.H. 1992: What's holding up animal drug approval? Journal of the American Veterinary Medical Association 200(12): 1806-1808
Morrow, T. 2015: A Rare Approval. FDA OKs Pediatric Cancer Drug Managed Care 24(10): 42-43
Otsuka, Y. 2012: Drug approval lag in Japan and drugs for children No to Hattatsu 44(1): 2
Kahn, L.G. 1998: Research resources for aquaculture drug development and approval Veterinary and Human Toxicology 40(Suppl 2): 41-43
1991: Pre-approval inspections/investigations. Food and Drug Administration Journal of parenteral science and technology: a publication of the Parenteral Drug Association 45(1): 56-66
Shultz, P.T.; Langan, M.J. 1989: Current developments in employee benefits. The IRS issues proposed Section 89 and cafeteria plan regulations Employee Relations Law Journal 15(1): 135-145
Niimi, S. 2015: Development of guidance for the approval process of brand-new medical products and regenerative medicine products Kokuritsu Iyakuhin Shokuhin Eisei Kenkyujo Hokoku 133: 1-7
de Graeff PA; Hoppe 1996: The use of ambulatory blood pressure monitoring to evaluate antihypertensive drugs for drug approval Blood Pressure Monitoring 1(3): 313-315
Gessler, M. 1982: Veterinary dispensary law and drug regulations Tierarztliche Praxis 10(1): 1-10